Genelux Corp (NASDAQ:GNLX) shares, rose in value on Thursday, April 16, with the stock price up by 2.33% to the previous day’s close as strong demand from buyers drove the stock to $2.63.
Actively observing the price movement in the last trading, the stock closed the session at $2.57, falling within a range of $2.55 and $2.67. The value of beta (5-year monthly) was -0.395. Referring to stock’s 52-week performance, its high was $5.89, and the low was $1.60. On the whole, GNLX has fluctuated by -34.25% over the past month.
With the market capitalization of Genelux Corp currently standing at about $99.22 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-27.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that GNLX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of GNLX currently trading nearly -3.82% and -28.70% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.31, while the 7-day volatility ratio is showing 9.60% which for the 30-day chart, stands at 11.15%. Furthermore, Genelux Corp (GNLX)’s beta value is -0.18, and its average true range (ATR) is 0.32.
A comparison of Genelux Corp (GNLX) with its peers suggests the former has fared considerably weaker in the market. GNLX showed an intraday change of 2.33% in last session, and over the past year, it shrunk by -25.28%%.
Data on historical trading for Genelux Corp (NASDAQ:GNLX) indicates that the trading volumes over the past 10 days have averaged 0.23 and over the past 3 months, they’ve averaged 260.33K. According to company’s latest data on outstanding shares, there are 34.73 million shares outstanding.
Nearly 13.02% of Genelux Corp’s shares belong to company insiders and institutional investors own 13.01% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.56 million shares as on 2025-03-31, resulting in a short ratio of 14.48. According to the data, the short interest in Genelux Corp (GNLX) stood at 797.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 2.45 million. The stock has risen by 11.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GNLX stock heading into the next quarter.
